Vasileios Papastamopoulos

Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial

George R. Thompson, Àlex Soriano, Oliver A. Cornely et al. · The Lancet · 2022 · 168 citations · Full text

Life Sciences, Microbiology, Pharmacology +16

Longitudinal trends in causes of death among adults with HIV on antiretroviral therapy in Europe and North America from 1996 to 2020: a collaboration of cohort studies

Adam Trickey, Kathleen A. McGinnis, M. John Gill et al. · The Lancet HIV · 2024 · 149 citations · Full text

Public Health, Population Health Sciences, Clinical Epidemiology +15

Evolocumab in HIV-Infected Patients With Dyslipidemia

Franck Boccara, Princy Kumar, Bruno Caramelli et al. · Journal of the American College of Cardiology · 2020 · 62 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Cardiovascular risk factors in HIV infected individuals: Comparison with general adult control population in Greece

Giota Touloumi, Natasa Kalpourtzi, Vasileios Papastamopoulos et al. · PLoS ONE · 2020 · 44 citations · Full text

Public Health, Health Sciences, Clinical Epidemiology +16

Prevalence of drug resistance among HIV-1 treatment-naive patients in Greece during 2003–2015: Transmitted drug resistance is due to onward transmissions

Dimitrios Paraskevis, Evangelia Georgia Kostaki, Gkikas Magiorkinis et al. · Infection Genetics and Evolution · 2017 · 34 citations

Life Sciences, Infectious Diseases, Microbiology +16